The results suggest that the role of FHL1 in tumor progression is dependent on the relative levels of Kindlin-2 and Src activity in cells, which determine whether FHL1 is anchored at focal adhesion sites and where it inhibits tumorigenesis. This evidence concerns the gene FHL1 and neoplasm.